Hepatitis
Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4). Wit...
| 出版年: | Canadian Journal of Infectious Diseases |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2001-01-01
|
| オンライン･アクセス: | http://dx.doi.org/10.1155/2001/428059 |
| _version_ | 1849437196522618880 |
|---|---|
| author | Mel Krajden |
| author_facet | Mel Krajden |
| author_sort | Mel Krajden |
| collection | DOAJ |
| container_title | Canadian Journal of Infectious Diseases |
| description | Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4). Without intervention, over multiple decades, approximately 15% to 30% of chronic HBV- and HCV-infected individuals will develop cirrhosis, end-stage liver disease or liver cancer, or will require liver transplantation (1,2,5). From a public health perspective, the major challenge is how best to avoid acute (incident) infections in at-risk populations, and for those already chronically infected, how to prevent consequent morbidity and mortality. |
| format | Article |
| id | doaj-art-7d66896e23a3418d86ea3debae4caefd |
| institution | Directory of Open Access Journals |
| issn | 1180-2332 |
| language | English |
| publishDate | 2001-01-01 |
| publisher | Wiley |
| record_format | Article |
| spelling | doaj-art-7d66896e23a3418d86ea3debae4caefd2025-08-20T03:35:18ZengWileyCanadian Journal of Infectious Diseases1180-23322001-01-0112632933110.1155/2001/428059HepatitisMel KrajdenWorldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV) and another 350 million individuals are chronically infected with hepatitis B virus (HBV) (1,2). Canada is estimated to have 240,000 to 300,000 HCV and 200,000 to 280,000 HBV chronic carriers (3,4). Without intervention, over multiple decades, approximately 15% to 30% of chronic HBV- and HCV-infected individuals will develop cirrhosis, end-stage liver disease or liver cancer, or will require liver transplantation (1,2,5). From a public health perspective, the major challenge is how best to avoid acute (incident) infections in at-risk populations, and for those already chronically infected, how to prevent consequent morbidity and mortality.http://dx.doi.org/10.1155/2001/428059 |
| spellingShingle | Mel Krajden Hepatitis |
| title | Hepatitis |
| title_full | Hepatitis |
| title_fullStr | Hepatitis |
| title_full_unstemmed | Hepatitis |
| title_short | Hepatitis |
| title_sort | hepatitis |
| url | http://dx.doi.org/10.1155/2001/428059 |
| work_keys_str_mv | AT melkrajden hepatitis |